 |
It has been suggested that this article or section be merged with 3-oxo-5alpha-steroid 4-dehydrogenase. (Discuss) |
| steroid-5-alpha-reductase, alpha polypeptide 1 | |
|---|---|
| Identifiers | |
| Symbol | SRD5A1 |
| Entrez | 6715 |
| HUGO | 11284 |
| OMIM | 184753 |
| RefSeq | NM_001047 |
| UniProt | P18405 |
| Other data | |
| EC number | 1.3.99.5 |
| Locus | Chr. 5 p15 |
| steroid-5-alpha-reductase, alpha polypeptide 2 | |
|---|---|
| Identifiers | |
| Symbol | SRD5A2 |
| Entrez | 6716 |
| HUGO | 11285 |
| OMIM | 607306 |
| RefSeq | NM_000348 |
| UniProt | P31213 |
| Other data | |
| EC number | 1.3.99.5 |
| Locus | Chr. 2 p23 |
5-Alpha reductase is an enzyme involved in steroid metabolism.
Contents |
Function
It converts testosterone, the male sex hormone, into the more potent dihydrotestosterone:
Note the major difference — the Δ4,5 double-bond on the A (leftmost) ring. (The other differences between the diagrams are unrelated to chemical structure.)
Isoenzymes
There are two isoenzymes, steroid 5-alpha reductase 1 and 2 (SRD5A1 and SRD5A2).[1][2]
The second isoenzyme is deficient in 5-alpha-reductase deficiency, which leads to a form of intersexualism.
Production and inhibition
The enzyme is produced only in specific tissues of the male human body,[3] namely the skin, seminal vesicles, prostate and epididymis.
Inhibition of 5-alpha reductase results in decreased production of DHT, increased levels of testosterone, and, perhaps, increased levels of estradiol. Gynecomastia is a possible side-effect of 5-alpha reductase inhibition.
Pharmacology
5-Alpha-reductase inhibitor drugs are used in benign prostatic hyperplasia, prostate cancer, and baldness. Both isoforms are also produced in the brain, where they serve to create the neurosteroid Allopregnenolone (5AR type I) and convert T to DHT(5AR type II)(1). Finasteride inhibits the function of only one of the isoenzymes (type 2), whereas dutasteride inhibits both forms.
Research has indicated certain mushrooms have anti-5-alpha reductase activity.[4]
References
- ^ Killian J, Pratis K, Clifton RJ, Stanton PG, Robertson DM, O'Donnell L (May 2003). "5alpha-reductase isoenzymes 1 and 2 in the rat testis during postnatal development". Biol. Reprod. 68 (5): 1711–8. doi:. PMID 12606426. http://www.biolreprod.org/cgi/pmidlookup?view=long&pmid=12606426.
- ^ Thiele S, Hoppe U, Holterhus PM, Hiort O (June 2005). "Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males". Eur. J. Endocrinol. 152 (6): 875–80. doi:. PMID 15941927. http://eje-online.org/cgi/pmidlookup?view=long&pmid=15941927.
- ^ Pinna G, Agis-Balboa RC, Pibiri F, Nelson M, Guidotti A, Costa E (October 2008). "Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice". Neurochem. Res. 33 (10): 1990–2007. doi:. PMID 18473173. http://dx.doi.org/10.1007/s11064-008-9718-5.
- ^ Chen, S., Y.C. Kao (1997), "Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase.", The Journal of Steroid Biochemistry and Molecular Biology (City of Hope, Duarte, California) 61: 107-115
See also
External
|
||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This EC 1.3 enzyme-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
